Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Conduction System Pacing: A Fresh Look
Author(s): Óscar Cano , Marek Jastrzębski , Pugazhendhi Vijayaraman Start date: Nov 13, 2024
Conduction System Pacing: Recent Advances and Clinical ApplicationsConduction system pacing (CSP) has significantly evolved in recent years, expanding from His bundle pacing to include left bundle branch pacing and left ventricular septal pacing. This webinar, led by Dr Pugazhendhi Vijayaraman, a renowned expert in the field, features presentations from esteemed faculty, Prof Marek Jastrzębski… View more

Heart Failure

Electrophysiology & Arrhythmia
Ethical and Regulatory Frameworks Post-AI Act in Clinical Research
Author(s): Andrea Barucci , Valentina Colcelli , Salvatore De Masi , et al Added: 4 days ago

Digital Health

Guidelines & Statements
AHA 25: Lp(a) and ASCVD: Translating Causal Evidence into Clinical Practice
Author(s): Michelle O'Donoghue Added: 2 months ago
AHA Scientific Sessions 2025 - Dr Michelle O'Donoghue (Brigham and Women's Hospital, US) joins us to discuss the evolving understanding of the causal relationship between elevated lipoprotein(a) and atherosclerotic cardiovascular disease, and what this means for risk stratification and management strategies in clinical practice.Dr O'Donoghue begins by highlighting the importance for clinicians to… View more

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
ADA 25: Clinical Implications of STRIDE for Endocrinologists
Author(s): Added: 6 months ago
ADA 2025 - We are joined by Dr Alice Cheng (University of Toronto, Toronto, CA) to discuss the clinical implications of STRIDE (NCT04560998). The placebo-controlled study investigated whether semaglutide with standard-of-care treatment has an effect on walking ability in patients with PAD and T2D. The primary outcome measure was the change in maximum walking distance on a constant load treadmill… View more

Cardiovascular Renal Metabolic

Vascular Disease and Surgery
Clinical Clues in Cardiovascular Disease
Author(s): Eva Gerdts , Faizel Osman , Yassir Javaid Added: 4 months ago
This six-part interview series, recorded around ESC 2025, brings together leading experts to share strategies for earlier and more accurate detection of cardiovascular disease. The discussions highlight how atypical or subtle symptoms of stroke and heart failure can delay diagnosis, and why vigilance in routine practice is critical.The series also examines sex-specific differences in cardiac… View more

CV Disease in Special Populations

Electrophysiology & Arrhythmia
TAVI Head-To-Head: Design, Data and Directions for Clinical Practice
Author(s): Martin Swaans , Vijay Kunadian , , et al Start date: Apr 23, 2024
This live broadcast, chaired by Dr Martin Swaans (St Antonius Hospital, NL), will explore the evolving data for transcatheter aortic valve implantation (TAVI) and why we need to improve triaging practices towards the most appropriate interventions.Join leading experts, Prof Sabine Bleiziffer (Heart and Diabetes Center NRW, DE), Prof Vijay Kunadian (Newcastle University, UK) and Dr Marta Sitges … View more

Intervention
TAVI Head-To-Head: Design, Data and Directions for Clinical Practice
Author(s): Martin Swaans , Vijay Kunadian , , et al Added: 1 year ago
In this on-demand version of the live broadcast, chaired by Dr Martin Swaans (St Antonius Hospital, NL), faculty explore the evolving data for transcatheter aortic valve implantation (TAVI) and why we need to improve triaging practices towards the most appropriate interventions.Leading experts, Prof Sabine Bleiziffer (Heart and Diabetes Center NRW, DE), Prof Vijay Kunadian (Newcastle University,… View more

Intervention
AHA 23 Late-Breaker Discussion: The ARIES HM3 Clinical Trial
Author(s): Harriette Van Spall , Mandeep Mehra Added: 2 years ago
AHA 23 - Investigator, Dr Mandeep R Mehra (Brigham and Women's Hospital and Harvard Medical School, US) is joined by Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the ARIES HM3 trial.ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were… View more

Heart Failure

Electrophysiology & Arrhythmia
Clinical Management of Non-alcoholic Steatohepatitis
Author(s): Carlos Millán-Rodríguez , Carlos Palacios Castelló , María de Regla Caballero-Valderrama , et al Added: 2 years ago

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Meta-analysis and Meta-regression Applicability
Author(s): Alberto Cordero , Carlos G Santos-Gallego , Armando Oterino , et al Added: 3 months ago

CV Disease in Special Populations